Tower Trust & Investment CO Abb Vie Inc. Transaction History
Tower Trust & Investment CO
- $124 Billion
- Q1 2025
A detailed history of Tower Trust & Investment CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Tower Trust & Investment CO holds 700 shares of ABBV stock, worth $133,049. This represents 0.11% of its overall portfolio holdings.
Number of Shares
700Holding current value
$133,049% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
4,240Shares Held
1.27BCall Options Held
16.8MPut Options Held
14.1M-
Vanguard Group Inc Valley Forge, PA174MShares$33.1 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.4 Billion0.9% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.54 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $336B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...